Location History:
- Wilmington, DE (US) (1979 - 1980)
- Cheshire, GB (1984)
- Tytherington, GB (1983 - 1987)
- Macclesfield, GB (1982 - 1989)
Company Filing History:
12 out of 3,840 
6 out of 432 Years Active: 1979-1989
Title: Derrick F Jones: Innovator in Pharmaceutical Chemistry
Introduction
Derrick F Jones is a notable inventor based in Tytherington, GB, recognized for his contributions to pharmaceutical chemistry. He holds a total of 13 patents, showcasing his innovative spirit and dedication to advancing medical science.
Latest Patents
Among his latest inventions are two significant patents related to histamine H-2 antagonists that inhibit gastric acid secretion. The first patent focuses on heterocyclic derivatives, which include a guanidine derivative with specific structural formulas. This invention aims to provide effective pharmaceutical compositions for treating conditions related to gastric acid secretion. The second patent involves amidine derivatives, also functioning as histamine H-2 antagonists, with a similar goal of inhibiting gastric acid secretion. Both patents describe manufacturing processes and the pharmaceutically-acceptable acid-addition salts of these compounds.
Career Highlights
Derrick has worked with prominent companies in the chemical industry, including Imperial Chemical Industries Limited and ICI Americas, Inc. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Throughout his career, Derrick has collaborated with notable colleagues, including Keith Oldham and Tobias O Yellin. These partnerships have likely enriched his work and led to further advancements in his field.
Conclusion
Derrick F Jones exemplifies the spirit of innovation in pharmaceutical chemistry through his patents and collaborations. His work continues to impact the medical field positively, particularly in the development of treatments for gastric acid-related conditions.